Egalet
Wayne, US · Delaware corporation · 1 known investors
Egalet is a specialty pharmaceutical company developing pain management and opioid products with abuse-deterrent technology. The company serves patients and healthcare providers in the pharmaceutical market.
BiotechMedical Devices
Founders & leadership
AH
ANDREA HESLIN SMILEYDirector
JM
JOSEPH MCINNISDirector
BA
BARBARA A. CARLINSENIOR VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER
MP
MATTHEW PAULSDirector
TH
TODD HOLMESDirector
RS
ROBERT S. RADIECHIEF EXECUTIVE OFFICER
TP
TIMOTHY P. WALBERTDirector
MS
MARK STROBECKEXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER
MT
MEGAN TIMMINSSENIOR VICE PRESIDENT AND GENERAL COUNSEL
LD
LUKE DUSTERDirector
PM
PATRICK M. SHEASENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER
JM
Jeffrey M. DaynoChief Medical Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$42.2MraisedFeb 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$42.2MraisedFeb 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- ANDREA HESLIN SMILEYDirector
- JOSEPH MCINNISDirector
- BARBARA A. CARLINExecutive Officer
- MATTHEW PAULSDirector
- TODD HOLMESDirector
- ROBERT S. RADIEExecutive Officer, Director
- TIMOTHY P. WALBERTDirector
- MARK STROBECKExecutive Officer
- MEGAN TIMMINSExecutive Officer
- LUKE DUSTERDirector
- PATRICK M. SHEAExecutive Officer
- Offering amount
- $42.2M
- Amount sold
- $42.2M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.